PointState Capital’s Allergan Inc AGN Stock Holding History

PointState Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-464,800	Closed	-$98.8M	–	172
2014 Q4	$98.8M	Buy	+464,800	New	+$92.4M	1.68%	23
2014 Q3	–	Sell	-231,000	Closed	-$39.1M	–	164
2014 Q2	$39.1M	Buy	+231,000	New	+$36M	0.49%	38
2014 Q1	–	Sell	-200,000	Closed	-$22.2M	–	193
2013 Q4	$22.2M	Sell	200,000 -2,202,380	-92%	-$210M	0.28%	66
2013 Q3	$217M	Buy	2,402,380 +1,021,980	+74%	+$91.7M	3.72%	5
2013 Q2	$116M	Buy	+1,380,400	New	+$143M	2%	12

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

PointState Capital's AGN Position: Q1 2015 in Review

PointState Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 464,800 shares — an estimated $98.8M sold.

PointState Capital first reported a position in AGN in Q2 2013 and held it in 5 quarters. The position peaked at $217M in Q3 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

PointState Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
PointState Capital sold 464,800 Allergan Inc shares in Q1 2015, an estimated $98.8M.
PointState Capital first reported a position in Allergan Inc in Q2 2013 and held it in 5 quarters.
PointState Capital's Allergan Inc position peaked at $217M in Q3 2013.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on PointState Capital's 13F filing for Q1 2015, filed 15 May 2015.